Nascent Biotech Stock Probability of Future OTC Stock Price Finishing Under 0.0599
| NBIO Stock | USD 0.06 0.01 11.93% |
Nascent |
Nascent Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nascent Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nascent Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nascent Biotech is way too risky over 90 days horizon | |
| Nascent Biotech has some characteristics of a very speculative penny stock | |
| Nascent Biotech appears to be risky and price may revert if volatility continues | |
| Nascent Biotech currently holds 64.89 K in liabilities. Nascent Biotech has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nascent Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Nascent Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nascent Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nascent to invest in growth at high rates of return. When we think about Nascent Biotech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1000 K. Net Loss for the year was (470.39 K) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| About 32.0% of the company outstanding shares are owned by corporate insiders |
Nascent Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nascent OTC Stock often depends not only on the future outlook of the current and potential Nascent Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nascent Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 111.3 M |
Nascent Biotech Technical Analysis
Nascent Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Nascent OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nascent Biotech. In general, you should focus on analyzing Nascent OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Nascent Biotech Predictive Forecast Models
Nascent Biotech's time-series forecasting models is one of many Nascent Biotech's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nascent Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Nascent Biotech
Checking the ongoing alerts about Nascent Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nascent Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nascent Biotech is way too risky over 90 days horizon | |
| Nascent Biotech has some characteristics of a very speculative penny stock | |
| Nascent Biotech appears to be risky and price may revert if volatility continues | |
| Nascent Biotech currently holds 64.89 K in liabilities. Nascent Biotech has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nascent Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Nascent Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nascent Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nascent to invest in growth at high rates of return. When we think about Nascent Biotech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1000 K. Net Loss for the year was (470.39 K) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| About 32.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Nascent OTC Stock
Nascent Biotech financial ratios help investors to determine whether Nascent OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nascent with respect to the benefits of owning Nascent Biotech security.